Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MoonLake Immunotherapeutics (MLTX) Prepaid Assets (2020 - 2026)

MoonLake Immunotherapeutics' Prepaid Assets history spans 7 years, with the latest figure at $33.0 million for Q1 2026.

  • Quarterly Prepaid Assets rose 42.39% to $33.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $33.0 million through Mar 2026, up 42.39% year-over-year, with the annual reading at $22.9 million for FY2025, 2.4% down from the prior year.
  • Prepaid Assets came in at $33.0 million for Q1 2026, up from $22.9 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $33.0 million in Q1 2026 to a low of $135916.0 in Q1 2022.
  • The 5-year median for Prepaid Assets is $5.1 million (2022), against an average of $12.9 million.
  • The largest YoY upside for Prepaid Assets was 2415.82% in 2022 against a maximum downside of 53.07% in 2022.
  • MoonLake Immunotherapeutics' Prepaid Assets stood at $4.2 million in 2022, then plummeted by 49.7% to $2.1 million in 2023, then surged by 1013.97% to $23.4 million in 2024, then fell by 2.4% to $22.9 million in 2025, then surged by 44.19% to $33.0 million in 2026.
  • Per Business Quant, the three most recent readings for MLTX's Prepaid Assets are $33.0 million (Q1 2026), $22.9 million (Q4 2025), and $26.7 million (Q3 2025).